Penn Medicine Provider
Radiation Oncology
Edgar Ben-Josef, MD
5.0
(46)
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman - 2nd Floor

About me

  • Vice Chair, Translational Research, Radiation Oncology
  • Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Hebrew-Hadassah University
  • Residency: Beilinson Medical Center
  • Residency: Harper Hospital

What my patients think about me

Average Rating
5.0

46 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
very informative
April 2025
5.0
5.0
takes the time to explain things well and really wants to try and help
April 2025
5.0
5.0
dr ben josef was great! he answered all my questions and put my mind at ease.
March 2025
5.0
5.0
very helpful

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Ben-Josef is a Penn Medicine physician.

Qualifications and experience

My research

Edgar Ben-Josef 1, Andrew M Lowy 2 A Novel Adjuvant Chemoradiotherapy/Immunotherapy for Resected Biliary Cancer , JAMA Oncol: 2025


Uri Amit 1 2, James M Metz 2, John P Plastaras 2, Rohi Gheewala 2, Ursina Teitelbaum 3, Nevena Damjanov 3, Charles Vollmer 4, Charles J Schneider 3, Major Kenneth Lee 4th 4, Mark O'Hara 3, Kim Reiss-Binder 3, Erica L Carpenter 3, Thomas B Karasic 3, Andre Konski 2, E Paul Wileyto 5, Edgar Ben-Josef 2 A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer , Cancer, 131(12): 2025,e35936


Grace Lee 1, Bailey Nelson 2, Julie Koenig 1, John P Plastaras 3, James M Metz 3, Beow Y Yeap 4, Yongbin Zhang 2, Lorraine C Drapek 1, Christian Baglini 4, David P Ryan 4, Aparna R Parikh 4, Jill N Allen 4, Jeffrey W Clark 4, Lawrence S Blaszkowsky 4, Edgar Ben-Josef 3, Theodore S Hong 1, Jordan R Kharofa 5, Jennifer Y Wo 6 Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials , Int J Radiat Oncol Biol Phys, 122(1): 2025


Timothy J Brown 1, Uri Amit 2, Rohi Gheewala 2, Edgar Ben-Josef 2, Thomas B Karasic 2 Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Analysis , Am J Clin Oncol, 10.1097/COC.0000000000001214: 2025


Steven Joel Feigenberg 1, Francesca Costabile 1, Ceylan Tanes 2, Kyle Bittinger 2, Roderick O'Connor 3, Divyansh Agarwal 4, Giorgos Skoufos 5, Silavano Salaris 6, Artemis Hatzigeorgiou 5, Nektarios Kostopoulos 1, Shane Lloyd 7, Cole Friedes 1, Lisha Chen 1, Nikhil Yegya-Raman 1, Keith Cengel 1, William Levin 1, Bakir Valentić 3, Tyler Quarton 8, Alexander A Shestov 9, Abigail Berman 10, Jeffrey Bradley 1, Amit Maity 7, Costantinos Koumenis 1, Edgar Ben-Josef 1, Andrea Facciabene 11 12 Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study , J Immunother Cancer, 13(7): 2025


Uri Amit MD MPH PhD 1, Misra Shagun MD2, John P Plastaras MD PhD1, James M Metz MD1, Thomas B Karasic MD3, Maryanne J Lubas MD4 and Edgar Ben-Josef MD1 Clinical Outcomes and Risk Stratification in Unresectable Biliary Tract Cancers Undergoing Radiation Therapy , ASTRO 2024 Annual Meeting, 19(1): 2024


Uri Amit, Ugur Uslu, Ioannis I. Verginadis, Michele M. Kim, Seyyedeh Azar Oliaei Motlagh, Charles-Antoine Assenmacher, Sandra Bicher, Edgar Ben-Josef, Regina M. Young, Carl H. June, Constantinos Koumenis "Proton Radiation Boosts Efficacy of Mesothelin-targeting Chimeric Antigen Receptor T Cell Therapy in Pancreatic Cancer" , PNAS, 121(31): 2024


Grace Lee MDa, Bailey Nelson MDb, Julie Koenig MDa, John P. Plastaras MDc, James M. Metz MDc, Beow Y. Yeap ScDa, Lorraine C. Drapek DNPa, Christian Baglini NPb, David P Ryan MDd, Aparna R Parikh MDd, Jill N Allen MDd, Jeffrey W. Clark MD PhDd, Lawrence S Blaszkowsky MDd, Edgar Ben-Josef MDc, Theodore S. Hong MDa, Jordan R. Kharofa MDb*, Jennifer Y. Wo MD Long -term Outcomes of Definitive Chemoradiation with Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials , ASTRO 2024 Annual Meeting: 2024


Uri Amita, Ugur Uslub, Ioannis I. Verginadisa, Michele M. Kima, Seyyedeh Azar Oliaei Motlagh, Eric S. Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Edgar Ben-Josef, Regina M. Young, Carl H. Juneb, Constantinos Koumenisa Proton Radiation Boosts Efficacy of Mesothelin-targeting Chimeric Antigen Receptor T Cell Therapy in Pancreatic Cancer , ASTRO 2024 Annual Meeting: 2024


Melinda D. Jing; Michelle Iocolano MD; Wei Xu MB, MBE; Wencesley Paez MD, MSHS; Steven Feigenberg MD; Peter Gabriel, MD, MSE; Constantinos Koumenis PhD; Edgar Ben-Josef MD & John P. Plastaras MD, PhD Implementation of a Radiation Oncology Protocol Committee for Clinical Trial Review and Prioritization , ASTRO 2024 Annual Meeting: 2024